Clinical Roundup Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer February 20, 2026Vol.52 No.07
Clinical Roundup Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma February 20, 2026Vol.52 No.07
Clinical Roundup Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds February 20, 2026Vol.52 No.07
Clinical Roundup Different KRAS mutations affect how tumors interact with the immune system, UTSW-led study finds February 20, 2026Vol.52 No.07
Clinical Roundup Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds February 20, 2026Vol.52 No.07
Drugs & Targets FDA grants Breakthrough Therapy designation to Rybrevant Faspro in advanced head-and-neck cancer February 20, 2026Vol.52 No.07
Drugs & Targets Siemens Healthineers and Mayo Clinic collaborate to improve care for neurodegenerative disease, cancer February 20, 2026Vol.52 No.07
Drugs & Targets PharmaMar, Globant collaborate to accelerate oncology research with AI February 20, 2026Vol.52 No.07
